Pennsylvania Hospital is a private, non-profit, 515-bed teaching hospital located in Center City Philadelphia and is part of the University of Pennsylvania Health System.

There are 515 beds in Pennsylvania Hospital.

During the past decade, Pennsylvania Hospital conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 53 clinical trials were completed, i.e. on average, 115.2% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 24 clinical trials were completed. i.e. 160% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pennsylvania Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 33 trials, followed by "University of Pennsylvania" with 22 trials sponsored, "Gynecologic Oncology Group" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include 51 different institutions and companies that sponsored additional 51 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pennsylvania Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator and "Medical University of South Carolina" with 3 trials as a collaborator. Other collaborators include 141 different institutions and companies that were collaborators in the rest 128 trials.

According to Clinical.Site data, the most researched conditions in "Pennsylvania Hospital" are "Fallopian Tube Endometrioid Adenocarcinoma" (7 trials), "Ovarian Cancer" (7 trials), "Ovarian Endometrioid Adenocarcinoma" (7 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (6 trials) and "Fallopian Tube Mucinous Adenocarcinoma" (6 trials). Many other conditions were trialed in "Pennsylvania Hospital" in a lesser frequency.

Most popular intervention types in "Pennsylvania Hospital" are "Drug" (78 trials), "Other" (55 trials), "Biological" (30 trials), "Procedure" (16 trials) and "Device" (15 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (28 trials), "Quality-of-Life Assessment" (17 trials), "Paclitaxel" (16 trials), "Bevacizumab" (12 trials) and "Carboplatin" (12 trials). Other intervention names were less common.

The vast majority of trials in "Pennsylvania Hospital" are 86 trials for "All" genders and 46 trials for "Female" genders.

Currently, there are NaN active trials in "Pennsylvania Hospital". undefined are not yet recruiting, 12 are recruiting, 28 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 71 completed trials in Pennsylvania Hospital, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Pennsylvania Hospital, 10 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 26 trials that are defined as “Not Applicable".

Pennsylvania Hospital has several departments that took part in Clinical trials: "Abramson Cancer Center at Pennsylvania Hospital" - 8 trials